This announcement is a separate document:
国药一致：2023年第一季度业绩快报
Sinopharm is consistent: quick performance report for the first quarter of 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated